| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |